Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
Among oncolytic viruses, the vesicular stomatitis virus (VSV) is especially potent and a highly promising agent for the treatment of cancer. But, even though effective against multiple tumor entities in preclinical animal models, replication-competent VSV exhibits inherent neurovirulence, which has...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer-Verlag
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396339/ |